InfuSystem Holdings (INFU) Gross Margin (2010 - 2026)
InfuSystem Holdings (INFU) posted Gross Margin of 58.43% for Q1 2026, up 3.6% on a QoQ basis from 56.4% in Q4 2025, and up 322.0% year-over-year from 13.85% in Q1 2025.
InfuSystem Holdings (INFU) Gross Margin (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Gross Margin history runs 17 years deep, the most recent figure standing at 58.43% for Q1 2026.
- Quarterly Gross Margin rose 322.0% year-over-year to 58.43% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 56.75% (up 362.0% YoY) and the FY2025 annual result came in at 55.98%, up 378.0% from the prior year.
- Gross Margin was 58.43% for Q1 2026 at InfuSystem Holdings, up from 56.4% in the prior quarter.
- Across five years, Gross Margin topped out at 59.46% in Q3 2022 and bottomed at 48.81% in Q4 2022.
- A 5-year average of 53.67% and a median of 53.92% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin plunged 1052 bps — and 2025, when it soared 574 bps.
- InfuSystem Holdings' Gross Margin stood at 48.81% in 2022, then increased by 8 bps to 52.6% in 2023, then climbed by 2 bps to 53.82% in 2024, then rose by 5 bps to 56.4% in 2025, then increased by 4 bps to 58.43% in 2026.
- Business Quant data shows INFU's Gross Margin at 58.43% in Q1 2026, 56.4% in Q4 2025, and 57.06% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 58.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.43% |
| Dec 31, 2025 | 56.40% |
| Sep 30, 2025 | 57.06% |
| Jun 30, 2025 | 55.20% |
| Mar 31, 2025 | 55.21% |
| Dec 31, 2024 | 53.82% |
| Sep 30, 2024 | 53.92% |
| Jun 30, 2024 | 49.46% |
| Mar 31, 2024 | 51.49% |
| Dec 31, 2023 | 52.60% |
| Sep 30, 2023 | 48.94% |
| Jun 30, 2023 | 49.89% |
| Mar 31, 2023 | 49.23% |
| Dec 31, 2022 | 48.81% |
| Sep 30, 2022 | 59.46% |
| Jun 30, 2022 | 55.10% |
| Mar 31, 2022 | 57.42% |
| Dec 31, 2021 | 51.45% |
| Sep 30, 2021 | 57.43% |
| Jun 30, 2021 | 60.60% |